Stock Fundamentals

Company Information

Company Name
Alkermes Plc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: USG017671052
CIK: 0001520262
CUSIP: 01642T108
Currency: USD
Full Time Employees: 2,050
Phone: 353 1 772 8000
Fiscal Year End: December
IPO Date: Jul 16, 1991
Description:

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Address:

Connaught House, Dublin, Ireland, D04 C5Y6

Directors & Officers

Name Title Year Born
Mr. Richard F. Pops Chairman & CEO 1962
Mr. Joshua Reed M.B.A. Senior VP & CFO 1973
Mr. Blair C. Jackson Executive VP, Chief Risk Officer & COO 1973
Mr. David Joseph Gaffin J.D. Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary 1972
Dr. Craig C. Hopkinson M.D. Executive VP of Research & Development and Chief Medical Officer 1969
Mr. Christian Todd Nichols Senior VP & Chief Commercial Officer 1970
Mr. Samuel J. Parisi Interim Principal Accounting Officer & VP of Finance 1975
Mr. Tom Skoff SVP & Chief Information Officer NA
Ms. Sandra Coombs Senior Vice President of Corporate Affairs & Investor Relations NA
Mr. Stephen Schiavo Senior VP & Chief Human Resources Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 06, 2026 David Joseph Gaffin N/A Sale 2.03K $34.57 $70.32K
Apr 01, 2026 Craig C Hopkinson N/A Sale 9.00K $35.51 $319.59K
Mar 02, 2026 Christian Todd Nichols N/A Sale 6.00K $30.00 $180.00K
Mar 02, 2026 Craig C Hopkinson N/A Sale 9.00K $29.72 $267.48K
Mar 02, 2026 David Joseph Gaffin N/A Sale 2.03K $29.29 $59.58K
Feb 02, 2026 Craig C Hopkinson N/A Sale 9.00K $33.93 $305.37K
Feb 02, 2026 Shane Cooke N/A Sale 61.20K $34.57 $2.12M
Feb 02, 2026 Shane Cooke N/A Sale 61.20K $34.57 $2.12M
Jan 08, 2026 Craig C Hopkinson N/A Sale 5.00K $30.00 $150.00K
Jan 02, 2026 Craig C Hopkinson N/A Sale 4.00K $28.00 $112.00K
Dec 03, 2025 Craig C Hopkinson N/A Sale 3.75K $30.00 $112.44K
Dec 01, 2025 Craig C Hopkinson N/A Sale 4.00K $29.30 $117.20K
Nov 03, 2025 Craig C Hopkinson N/A Sale 9.00K $30.38 $273.42K
Oct 15, 2025 Craig C Hopkinson N/A Sale 9.00K $31.53 $283.77K
Jun 10, 2025 Christian Todd Nichols N/A Sale 3.33K $31.09 $103.65K
Jun 09, 2025 Christian Todd Nichols N/A Sale 3.33K $31.95 $106.49K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 28.31M Mar 31, 2026 16.99% $0.02 0.15%
Vanguard Group Inc 18.01M Dec 31, 2025 10.80% $0.01 -0.95%
Baker Bros Advisors LP 10.01M Mar 31, 2026 6.01% $2.03 0.00%
Vanguard Portfolio Management, LLC 9.51M Mar 31, 2026 5.71% $0.02 0.00%
State Street Corp 9.47M Mar 31, 2026 5.68% $0.01 -0.08%
Vanguard Capital Management, LLC 7.43M Mar 31, 2026 4.46% $0.01 0.00%
Renaissance Technologies Corp 6.16M Mar 31, 2026 3.70% $0.34 -7.61%
American Century Companies Inc 6.07M Mar 31, 2026 3.64% $0.11 1.94%
T. Rowe Price Associates, Inc. 4.66M Mar 31, 2026 2.80% $0.02 -48.17%
Dimensional Fund Advisors, Inc. 4.52M Mar 31, 2026 2.71% $0.03 2.48%
COMMODORE CAPITAL LP 4.20M Mar 31, 2026 2.52% $8.59 18.31%
Geode Capital Management, LLC 4.18M Mar 31, 2026 2.51% $0.01 2.49%
JPMorgan Chase & Co 4.10M Mar 31, 2026 2.46% $0.01 -20.88%
Deep Track Capital, LP 3.59M Mar 31, 2026 2.15% $2.07 79.52%
Wellington Management Company LLP 2.97M Mar 31, 2026 1.78% $0.02 -1.66%
First Trust Advisors L.P. 2.97M Mar 31, 2026 1.78% $0.08 104.18%
PRIMECAP Management Company 2.54M Mar 31, 2026 1.52% $0.07 -0.95%
Nuveen, LLC 2.46M Mar 31, 2026 1.48% $0.02 1.38%
Holocene Advisors, LP 2.32M Mar 31, 2026 1.39% $0.20 0.00%
Citadel Advisors Llc 2.24M Mar 31, 2026 1.34% $0.01 87.07%

Shares Statistics

Shares Outstanding: 166.68M
Shares Float: 154.08M
% Insiders: 142.70%
% Institutions: 11,036.10%
Short % Float: 14.47%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 10.02M 6.01% ▲ 0.03% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 5.30M 3.18% ▲ 0.27% Apr 30, 2026
3 iShares Russell 2000 ETF 3.87M 2.32% ▲ 0.93% May 29, 2026
4 Vanguard Small Cap Index 3.84M 2.30% ▼ 0.20% Apr 30, 2026
5 State Street® SPDR® S&P® Biotech ETF 3.38M 2.03% ▼ 0.61% May 31, 2026
6 Avantis US Small Cap Value ETF 3.27M 1.96% ▲ 0.00% May 30, 2026
7 First Trust NYSE Arca Biotech ETF 2.32M 1.39% ▼ 0.43% May 31, 2026
8 Vanguard Small Cap Growth Index Inv 2.15M 1.29% ▼ 0.07% Apr 30, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 1.86M 1.12% ▲ 0.93% Apr 30, 2026
10 T. Rowe Price US Mid-Cap Value Equity 1.78M 1.07% ▼ 52.46% Mar 31, 2026

Valuation Metrics

Enterprise Value: $8.45B
Trailing P/E: 49.20
Forward P/E: 116.28

Financial Highlights

Market Cap: $7.38B
EBITDA: $278.58M
P/E Ratio: $49.20
PEG Ratio: $1.96
Book Value: $10.52
Earnings/Share: $0.90
Profit Margin: 9.77%
Operating Margin: -0.19%
ROA (TTM): 4.72%
ROE (TTM): 9.36%
Revenue (TTM): $1.56B
Revenue/Share (TTM): $9.45
Earnings Growth (YOY): -67.00%
Revenue Growth (YOY): 28.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.55x 0.00x 0.28x 20.69x 0.02x
2024-12-31 3.04x 0.00x 0.29x 18.63x 0.01x
2023-12-31 2.86x 0.25x 0.44x 17.98x 0.57x
2022-12-31 2.27x 0.29x 0.47x -0.47x 5.07x
2021-12-31 2.25x 0.28x 0.45x 8.71x 1.76x
2020-12-31 2.53x 0.27x 0.45x -12.98x -48.26x
2019-12-31 2.46x 0.26x 0.40x -12.90x -2.77x
2018-12-31 2.89x 0.24x 0.36x -6.42x -35.49x
2017-12-31 3.32x 0.23x 0.33x -12.32x -8.60x
2016-12-31 4.30x 0.23x 0.30x -14.01x -2.70x
2015-12-31 4.31x 0.27x 0.29x -16.93x -2.80x
2014-12-31 8.02x 0.26x 0.27x -6.49x 3.67x
2013-12-31 5.65x 0.68x 0.32x N/A 10.88x
2012-12-31 4.75x 0.42x 0.35x 1.67x 3.49x
2011-12-31 3.80x 0.53x 0.41x 1.67x 2.85x
2010-12-31 7.21x 0.03x 0.13x -3.14x -0.32x
2009-12-31 4.47x 0.12x 0.20x -13.84x -1.48x
2008-12-31 5.10x 0.18x 0.19x -7.20x -5.54x
2007-12-31 9.83x 0.61x 0.53x 9.81x 1.20x
2006-12-31 14.77x 0.41x 0.47x -5.59x 9.99x
2005-12-31 6.24x 1.46x 0.66x 2.89x 12.22x
2004-12-31 9.62x 67.70x 0.99x 0.18x 11.34x
2003-12-31 3.90x 6.69x 0.91x -0.72x -2.46x
2002-12-31 4.04x 1.69x 0.67x -3.11x -1.93x
2001-12-31 3.72x 3.61x 0.80x -80.43x -3.17x
2000-12-31 3.95x 1.99x 0.69x -4.78x -4.65x
1999-12-31 15.40x 1.41x 0.60x -0.44x -10.27x
1998-12-31 6.44x 0.06x 0.24x -1.85x -0.14x
1997-12-31 8.72x 0.04x 0.24x -4.65x -0.26x
1996-12-31 10.96x 0.04x 0.24x -0.58x -0.58x
1995-12-31 7.56x 0.11x 0.42x -1.27x -0.26x
1994-12-31 3.96x 0.14x 0.42x -1.07x -0.30x
1993-12-31 3.84x 0.08x 0.31x -0.68x -0.25x
1992-12-31 8.67x 0.02x 0.12x -0.46x -0.05x
1991-12-31 35.69x 0.00x 0.03x -5.22x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ALKS.US!